Detalhe da pesquisa
1.
Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic.
Oncologist
; 26(4): 341-347, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33355953
2.
Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness.
J Am Acad Dermatol
; 80(1): 99-105.e5, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30447951
3.
Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences.
Eur J Cancer
; 174: 200-211, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36044814
4.
Nivolumab efficacy in leptomeningeal metastasis of renal cell carcinoma: a case report.
Tumori
; 106(6): NP76-NP78, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32041500
5.
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study.
Lung Cancer
; 150: 123-131, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33130353
6.
A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab.
J Thorac Oncol
; 15(6): e83-e85, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32243919
7.
CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab.
Eur J Cancer
; 97: 59-61, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29743138